NO974115L - Nye aminoalkanfosfinsyrer og deres salter - Google Patents

Nye aminoalkanfosfinsyrer og deres salter

Info

Publication number
NO974115L
NO974115L NO974115A NO974115A NO974115L NO 974115 L NO974115 L NO 974115L NO 974115 A NO974115 A NO 974115A NO 974115 A NO974115 A NO 974115A NO 974115 L NO974115 L NO 974115L
Authority
NO
Norway
Prior art keywords
ethyl
iodo
chloro
phenyl
salts
Prior art date
Application number
NO974115A
Other languages
English (en)
Other versions
NO974115D0 (no
Inventor
Stuart John Mickel
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of NO974115L publication Critical patent/NO974115L/no
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO974115D0 publication Critical patent/NO974115D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
    • C07F9/65517—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/301—Acyclic saturated acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/58—Pyridine rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/60—Quinoline or hydrogenated quinoline ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Air Bags (AREA)

Abstract

Forbindelse med formel I a) HO^g R" N. (i: hvor R står for dletoksymetyl, R^ står for hydrogen og R2 står for 2,6- eller 3,5-dlklorbenzyl, pyrld-3- ylmetyl, l-(4-metoksyfenyl)etyl, l-(4-klor-3-Jod- fenyl)etyl eller l-(3-klor-4-Jod-fenyl)etyl eller R^ står for hydroksy og R2 står for 3,4-dlklorbenzyl, 1- (3-klor-4-Jod-fenyl )etyl, l-(4-klor-3-Jod-fenyl)etyl eller l-(3,4-dlklorfenyl)etyl og R3 står for hydrogen, og deres farmasøytisk anvendbare salter har GABAg- antagonlstlske egenskaper og kan bli anvendt for behandling av sykdommer som påvirkes av GABAg-an- tagonlster.
NO974115A 1991-11-21 1997-09-08 Nye aminoalkanfosfinsyrer og deres salter NO974115D0 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH340491 1991-11-21

Publications (2)

Publication Number Publication Date
NO974115L true NO974115L (no) 1993-05-24
NO974115D0 NO974115D0 (no) 1997-09-08

Family

ID=4255259

Family Applications (4)

Application Number Title Priority Date Filing Date
NO92924479A NO924479L (no) 1991-11-21 1992-11-20 Nye aminoalkanfosfinsyrer og deres salter
NO974115A NO974115D0 (no) 1991-11-21 1997-09-08 Nye aminoalkanfosfinsyrer og deres salter
NO974116A NO974116D0 (no) 1991-11-21 1997-09-08 Nye aminoalkanfosfinsyrer og deres salter
NO974117A NO974117D0 (no) 1991-11-21 1997-09-08 Nye aminoalkanfosfinsyrer og deres salter

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO92924479A NO924479L (no) 1991-11-21 1992-11-20 Nye aminoalkanfosfinsyrer og deres salter

Family Applications After (2)

Application Number Title Priority Date Filing Date
NO974116A NO974116D0 (no) 1991-11-21 1997-09-08 Nye aminoalkanfosfinsyrer og deres salter
NO974117A NO974117D0 (no) 1991-11-21 1997-09-08 Nye aminoalkanfosfinsyrer og deres salter

Country Status (14)

Country Link
US (2) US5376684A (no)
EP (2) EP0543780A3 (no)
JP (1) JPH05247069A (no)
KR (1) KR930010047A (no)
AU (2) AU662938B2 (no)
CA (1) CA2083307A1 (no)
FI (1) FI925243A (no)
IL (1) IL103808A0 (no)
MX (1) MX9206702A (no)
NO (4) NO924479L (no)
NZ (1) NZ245185A (no)
PH (1) PH30097A (no)
TW (1) TW213466B (no)
ZA (1) ZA928979B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL98502A (en) * 1990-06-22 1998-04-05 Ciba Geigy Ag History of Aminoalkene Phosphine Acid, Process for Their Preparation and Pharmaceutical Preparations Containing Them
EP0543780A3 (en) * 1991-11-21 1993-09-01 Ciba-Geigy Ag Novel aminoalkanephosphinic acids and their salts
AU662404B2 (en) * 1992-05-08 1995-08-31 Novartis Ag Novel N-aralkyl- and N-heteroaralkyl-aminoalkanephosphinic acids
AU7130196A (en) * 1995-09-28 1997-04-17 Novartis Ag Novel hydroxylated and alkoxylated N- and/or P-aralkylphosphinic acid derivatives
EP1000071B1 (en) * 1997-06-23 2004-11-17 Polychip Pharmaceuticals Pty. Ltd. Gaba-c receptor antagonists for stimulating memory capacity
DE10014127A1 (de) * 2000-03-22 2001-10-18 Hassan Jomaa Verwendung von phosphororganischen Verbindungen zur Behandlung von Infektionen
US6462084B1 (en) 2001-05-14 2002-10-08 Brookhaven Science Associates, Llc Treatment for obsessive-compulsive disorder (OCD) and OCD-related disorders using GVG
AR045794A1 (es) * 2003-09-23 2005-11-16 Aventis Pharma Inc Procedimiento para preparar derivados de acido 3- amino-2- hidroxipropilfosfinico
GB0327186D0 (en) * 2003-11-21 2003-12-24 Novartis Ag Organic compounds
US7494985B2 (en) * 2004-11-03 2009-02-24 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs, methods of synthesis, and use
WO2006050471A2 (en) * 2004-11-03 2006-05-11 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs of sulfinic acids, methods of synthesis, and use
JP2008530125A (ja) * 2005-02-11 2008-08-07 アベンティス・ファーマスーティカルズ・インコーポレイテツド 置換されたプロパンホスフィン酸エステル
US7585996B2 (en) * 2006-09-15 2009-09-08 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs, methods of synthesis and use

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2440239A1 (de) * 1974-08-22 1976-03-04 Hoechst Ag Innere ammoniumsalze von phosphinsaeuren
EP0093081B1 (de) * 1982-04-23 1986-03-19 Ciba-Geigy Ag Herbizide und pflanzenwuchsregulierende Mittel
US4536355A (en) * 1982-10-08 1985-08-20 Zoecon Corporation Phenoxyphenylaminoalkylphosphinates useful in weed control
GB8425872D0 (en) * 1984-10-12 1984-11-21 Ciba Geigy Ag Chemical compounds
US5243062A (en) * 1984-10-12 1993-09-07 Ciba-Geigy Corporation Substituted propane-phosphonous acid compounds
DK704488D0 (da) * 1988-12-19 1988-12-19 Novo Industri As Nye n-substituerede azaheterocykliske carboxylsyrer
GB8728483D0 (en) * 1987-12-04 1988-01-13 Ciba Geigy Ag Chemical compounds
US5300679A (en) * 1987-12-04 1994-04-05 Ciba-Geigy Corporation Substituted propane-phosphinic acid compounds
US5190933A (en) * 1987-12-04 1993-03-02 Ciba-Geigy Corporation Substituted propane-phosphinic acid compounds
DK270488D0 (da) * 1988-05-18 1988-05-18 Novo Industri As Hidtil ukendte o-substituerede ketoximer
GB8820266D0 (en) * 1988-08-26 1988-09-28 Smith Kline French Lab Compounds
US5281747A (en) * 1989-05-13 1994-01-25 Ciba-Geigy Corporation Substituted aminoalkylphosphinic acids
GB8911017D0 (en) * 1989-05-13 1989-06-28 Ciba Geigy Ag Substituted aminoalkylphosphinic acids
US5190934A (en) * 1989-06-03 1993-03-02 Ciba-Geigy Corporation P-subsituted propane-phosphinic acid compounds
GB8912814D0 (en) * 1989-06-03 1989-07-19 Ciba Geigy Ag P-substituted propane-phospinic acid compounds
IL98502A (en) * 1990-06-22 1998-04-05 Ciba Geigy Ag History of Aminoalkene Phosphine Acid, Process for Their Preparation and Pharmaceutical Preparations Containing Them
EP0543780A3 (en) * 1991-11-21 1993-09-01 Ciba-Geigy Ag Novel aminoalkanephosphinic acids and their salts
AU662404B2 (en) * 1992-05-08 1995-08-31 Novartis Ag Novel N-aralkyl- and N-heteroaralkyl-aminoalkanephosphinic acids

Also Published As

Publication number Publication date
NO974117L (no) 1993-05-24
JPH05247069A (ja) 1993-09-24
EP0543780A3 (en) 1993-09-01
CA2083307A1 (en) 1993-05-22
IL103808A0 (en) 1993-04-04
NO974117D0 (no) 1997-09-08
TW213466B (no) 1993-09-21
FI925243A0 (fi) 1992-11-18
KR930010047A (ko) 1993-06-21
US5376684A (en) 1994-12-27
NO974115D0 (no) 1997-09-08
EP0543780A2 (de) 1993-05-26
NO924479L (no) 1993-05-24
ZA928979B (en) 1994-04-15
EP0767174A1 (de) 1997-04-09
MX9206702A (es) 1994-06-30
NO974116L (no) 1993-05-24
NO974116D0 (no) 1997-09-08
AU4045695A (en) 1996-04-26
AU2850492A (en) 1993-05-27
PH30097A (en) 1996-12-27
AU662938B2 (en) 1995-09-21
FI925243A (fi) 1993-05-22
NZ245185A (en) 1995-04-27
US5500418A (en) 1996-03-19
NO924479D0 (no) 1992-11-20

Similar Documents

Publication Publication Date Title
NO974115L (no) Nye aminoalkanfosfinsyrer og deres salter
ES2102195T3 (es) Derivados heterociclicos de acido carbonico que se fijan en receptores de retinoides.
NO20055565L (no) Anvendelse av derivater av 2,4-dihydro-[1,2,4]triazol-3-thion som inhibitorer av enzymet myeloperoksidase (MPO)
NO20100939L (no) Tioksantinderivater som myeloperoksidaseinhibitorer
NO922851L (no) Trifluormetylbenzylfosfonater som er nyttig for behandling av osteporose
YU74694A (sh) Morfolin i tiomorfolin antagonisti receptora tahikinina -
NO955074L (no) 1-substituerte istain- og oksindolderivater som inhibitorer til acetylkolinesterase
NO951266L (no) Imidazol-holdige inhibitorer for farnesyl-protein-transferase
NO20050087L (no) N-benzoylureido-kanelsyrederivater, fremgangsmate for fremstilling og anvendelse av disse
DE60305514D1 (de) Neue verwendung von benzothiazolderivaten
MX9701685A (es) Nuevos derivados de bencimidazol que tienen la actividad de inhibicion de la fosfodiestearasa cgmp.
TR199801000T2 (xx) Bile�ikler
DE69828284D1 (de) Naphthyridinderivate oder salze davon
NO20014241L (no) C16-umettede FP-selektive prostaglandinanaloger
NO20020523D0 (no) Nye 2-dekarboksy-2-fosfinikoprostaglandin F-analoger
NO974690D0 (no) Nye triazoloner som inhibitorer av apolipoprotein B-syntesen
DK0688218T3 (da) Interleukin-1-inhibitor
AR019197A1 (es) COMPUESTOS DERIVADOS DE PIPERIDINA ANTIHISTAMINICOS, COMPUESTOS INTERMEDIOS, PROCEDIMIENTO DE PREPARACIoN DE DERIVADOS DE PIPERIDINA Y PROCEDIMIENTOS DE PREPARACIoN DE INTERMEDIARIOS.
ATE403376T1 (de) Insektizid sowie verfahren zur bekämpfung von insekten
DK0888288T3 (da) Carboxylsyreamider med fungicid virkning
MX2023004677A (es) Moduladores de la via de respuesta integrada al estres.
NO995030L (no) 5-(2-imidazolinylamino)benzimidazolforbindelser nyttige som <alfa>-2-adrenoseptoragonister
ATE278676T1 (de) Imdazol-derivate, deren herstellung und deren verwendung als s-adenosylmethionin decarboxylase (=samdc) inhibitoren
ATE149836T1 (de) Anti-plasmin depressant
BG106254A (en) Mag expression promoters